Exponent - EXPO Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" EXPO shares.
View EXPO analyst ratings or view top-rated stocks.

2 brokers have issued 1-year price targets for Exponent's stock. Their EXPO share price forecasts range from $120.00 to $120.00. On average, they anticipate the company's stock price to reach $120.00 in the next year. This suggests a possible upside of 29.1% from the stock's current price.
View analysts price targets for EXPO or view top-rated stocks among Wall Street analysts.

Exponent's stock was trading at $99.09 at the start of the year. Since then, EXPO shares have decreased by 6.2% and is now trading at $92.93.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023.
View our EXPO earnings forecast.

Exponent, Inc. (NASDAQ:EXPO) posted its quarterly earnings results on Thursday, February, 2nd. The business services provider reported $0.44 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.04. The business services provider earned $112.59 million during the quarter, compared to the consensus estimate of $111.47 million. Exponent had a net margin of 19.94% and a trailing twelve-month return on equity of 30.00%. The firm's revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.38 EPS.

Exponent announced a quarterly dividend on Thursday, February 2nd. Investors of record on Friday, March 10th will be given a dividend of $0.26 per share on Friday, March 24th. This represents a $1.04 dividend on an annualized basis and a yield of 1.12%. The ex-dividend date of this dividend is Thursday, March 9th. This is a positive change from the stock's previous quarterly dividend of $0.24.
Read our dividend analysis for EXPO.

ETFs with the largest weight of Exponent (NASDAQ:EXPO) stock in their portfolio include Invesco S&P SmallCap Industrials ETF (PSCI), Invesco S&P SmallCap Quality ETF (XSHQ), iShares Emergent Food and AgTech Multisector ETF (IVEG), ProShares Russell 2000 Dividend Growers ETF (SMDV), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), Invesco S&P SmallCap Low Volatility ETF (XSLV), Franklin U.S. Small Cap Multifactor Index ETF (FLQS) and iShares S&P Small-Cap 600 Growth ETF (IJT).

Exponent (NASDAQ:EXPO) pays an annual dividend of $1.04 per share and currently has a dividend yield of 1.06%. The company has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 53.06%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EXPO will have a dividend payout ratio of 45.81% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EXPO.

Shares of Exponent split on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly minted shares were payable to shareholders after the closing bell on Wednesday, June 6th 2018. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

15 employees have rated Exponent Chief Executive Officer Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Exponent's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Neuberger Berman Group LLC (5.72%), Conestoga Capital Advisors LLC (4.70%), Geneva Capital Management LLC (2.75%), Geode Capital Management LLC (2.19%), Riverbridge Partners LLC (2.09%) and Morgan Stanley (2.09%). Insiders that own company stock include Bradley A James, Carol Lindstrom, George H Brown, Harri Kytomaa, John Pye, Maureen T F Reitman, Paul R Johnston, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss, Sally Shepard and Steven J Murray.
View institutional ownership trends.

Shares of EXPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EXPO stock can currently be purchased for approximately $92.93.

Exponent (NASDAQ:EXPO) has a market capitalization of $4.71 billion and generates $513.29 million in revenue each year. The business services provider earns $102.33 million in net income (profit) each year or $1.96 on an earnings per share basis.

The company employs 1,313 workers across the globe.

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The official website for the company is www.exponent.com. The business services provider can be reached via phone at (650) 326-9400, via email at investor-relations@exponent.com, or via fax at 650-326-8072.